Chang-Mau Shing

Title: Chang-Mau Shing: Innovator in Bifunctional Chelating Agents

Introduction

Chang-Mau Shing is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of peptide synthesis, particularly in the development of bifunctional chelating agents. His innovative work has implications for tumor imaging radiopharmaceuticals, showcasing the intersection of chemistry and medical technology.

Latest Patents

Chang-Mau Shing holds a patent for a "Method for synthesis of bifunctional chelating agents-peptides." This invention presents a novel approach to synthesizing BCA-peptides, which are crucial for various applications in medical imaging. The method involves coupling Fmoc-Thr(ol)-Terephthal-Acetal-Amide Resin with various amino acids to create a straight peptide-resin. The resulting compound undergoes a series of reactions, ultimately leading to a product labeled with radioisotope for tumor imaging.

Career Highlights

Chang-Mau Shing is affiliated with the Institute of Nuclear Energy Research, where he applies his expertise in peptide synthesis to advance research in nuclear medicine. His work has not only contributed to scientific knowledge but also has practical applications in healthcare.

Collaborations

Throughout his career, Chang-Mau Shing has collaborated with esteemed colleagues such as Te-Wei Lee and Shui-Tein Chen. These collaborations have fostered a productive research environment, leading to advancements in the field of nuclear medicine.

Conclusion

Chang-Mau Shing's innovative contributions to the synthesis of bifunctional chelating agents highlight his role as a key figure in the intersection of chemistry and medical technology. His work continues to influence the development of effective tumor imaging techniques.